Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) SHH

28.97

-0.24(-0.82%)

Updated at August 19 11:30AM

Currency In CNY

Vcanbio Cell & Gene Engineering Corp., Ltd

Address

Huayuan Industrial Park

Tianjin, 300384

China

Phone

86 22 5877 5766

Sector

Healthcare

Industry

Biotechnology

Employees

2209

First IPO Date

May 04, 1993

Key Executives

NameTitlePayYear Born
Mr. Yu ZhangR&D Director01985
Mr. Hongqi WangVice Chairman & GM01964
Mr. Hong Xiang ShiDeputy General Manager01983
Dr. Huang JiaxueChief Technical Quality Officer0N/A
Yi Qing ChenDeputy GM, Chief Financial Officer & Secretary0N/A
Mr. Yueming WangChief Human Resources Officer0N/A

Description

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.